Should I apply Tatva Chintan IPO?
Table of Contents
Should I apply Tatva Chintan IPO?
Most brokerages recommend ‘subscribe’ for Tatva Chintan Pharma IPO on the back of robust financials, strong growth potential, diversification, potential play on green chemistry, discounted valuation compared to its peers and niche global placement.
Should you subscribe to tatva Chintan Pharma Chem IPO?
Tatva Chintan Pharma Chem IPO — Should you subscribe? Here’s what analysts are saying. The IPO has a price band of ₹1,073-1,083 while it is looking to raise ₹500 crore through the public issue. Most analysts have suggested subscribing to the IPO for the long term on strong growth opportunities in global markets.
How is tatva Chintan IPO?
The stock got listed at Rs 2,111, with a gain of 95 per cent over the issue price of Rs 903 per share. It ended the session at Rs 2,310.25, with a gain of 113.3 per cent. The listing gain clocked by Tatva Chintan was highest for IPOs this year.
Is tatva Chintan a good investment?
“With strong fundamentals, we recommend investors to hold Tatva Chintan as long-term portfolio stock and further accumulate the counter on dips for the target of over Rs 3,500 in medium terms,” Matta mentioned.
Is tatva Chintan good company?
The company has a good business model and has promoters with good track record, said the Market Guru. “It’s an old company with experienced promoters. Also, the company promises good growth outlook with recent capex. This Rs 500 crore issue will further strengthen Tatva Chintan Pharma Chem Ltd’s capex.
Is Tatva Chintan a good investment?
Is Tatva Chintan IPO overpriced?
Tatva Chintan Pharma Chem made a stellar stock market debut, with its shares getting listed at a whopping 95 per cent premium over its issue price of Rs 1,083 per share on the National Stock Exchange (at Rs 2,111.85) and BSE (at Rs 2,111.80).
Is tatva Chintan IPO good for long term investment?
Most experts advise holding the stock for the long term in view of the company’s healthy financials, global presence and a strong product portfolio. Short-term investors, however, can book partial profits, they said. The stock opened at Rs 2,111.80 on the BSE, up 95 percent over the issue price of Rs 1,083.
Stocks to Buy Today: Best Shares to Buy in India
| Name | LTP | High |
|---|---|---|
| Bharti Airtel | 697.60 | 722 |
| Britannia Inds. | 3,496.20 | 3,581 |
| Cipla | 894.95 | 916 |
| Coal India | 148.55 | 152 |
Is it good to buy Tatva Chintan?
“Tatva Chintan stands well to get the favourable and supportive industry growth to drive sustainable business as well as profitable growth in the medium to long-term as it has well-diversified presence in pharmaceutical, agrochemical and automotive battery industry,” he said.
Should I buy Tatva Chintan after listing?
On advice to those who got Tatva Chintan shares allotted; Ravi Singhal of GCL Securities said, “Since, they are getting more than 100 per cent listing gains, I would advise them to book 50 per cent profit, fish out their principal and remain invested in the stock with their listing gains for at least 6-9 months.”
Is Tatva Chintan a good buy?
https://www.youtube.com/watch?v=KD1FhE2gRGM